written reports, including local media accounts, professional medical papers and internal emails were also examined.
.
.
'indian ip and liabilities law barrier to pharma r&d investment'
.
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation.
.
.
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”
.
.